In this study, we presented evidence of the effectiveness of treatment with incretin GLP-1 for the symptoms of obesity and diabetes, inflammation and emphysema, as well as stimulation of regeneration of damaged endothelium of the lungs in conditions of modeling obesity and emphysema. This evidence concerns the gene GCG and obesity disorder.